Craiglow BG and colleagues. Topical Ruxolitinib for the Treatment of Alopecia Universalis. JAMA Dermatology Published online December 9, 2015 In the last few years, the spotlight has been on two new drugs – tofacitinib and ruxolitinib as potential treatments for alopecia areata. Readers may remember the news story that broke in 2014 with the finding […]
CANAAF received an email from Laura Ralph the Director of Support & Education at NAAF inviting us to share it with you. The Journal of Investigative Dermatology (JID) is considered the leading voice in dermatologic research and the JID is a journal of investigative proceedings. Please click here to learn more.
NAAF’s Treatment Development Program (TDP) is on track with the timeline initiated in 2010 to accelerate our quest for a viable treatment. NAAF is serving as the ultimate concierge, leveraging all of our available research resources and clinical partnerships. Our strategic goal is to produce safe, effective, affordable treatments useful to millions of people with alopecia […]
EHRS is an independent, non-profit organization dedicated to promoting the research of hair biology and hair disease in Europe.